Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiopharmaceuticals
Biotech
AstraZeneca vows $15B China investment to boost R&D capabilities
AstraZeneca made a broad commitment to China to enhance its capabilities in areas including cell therapies and radioconjugates.
Nick Paul Taylor
Jan 29, 2026 5:50am
Radiopharma-focused Aktis bring in $318M via upsized IPO
Jan 9, 2026 4:52am
Fierce Pharma
3 biopharma CEOs explain why they are 'authentically optimistic'
Jan 6, 2026 11:54am
Aktis aims for $209M windfall from 1st biotech IPO of 2026
Jan 5, 2026 9:30am
Big Pharma-backed Aktis plans IPO to fund radiopharma trials
Dec 22, 2025 8:55am
Sanofi $110M radioligand therapy hits main goal in ph. 2 trial
Oct 8, 2025 6:25am
